These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

153 related articles for article (PubMed ID: 37860120)

  • 1. Key elements in the quality assessment of a type 3 medication review.
    Robberechts A; Michielsen M; Steurbaut S; De Meyer GRY; De Loof H
    Front Pharmacol; 2023; 14():1258364. PubMed ID: 37860120
    [No Abstract]   [Full Text] [Related]  

  • 2. [Information transmission to the community pharmacist after a patient's discharge from the hospital: setting up of a written medication discharge form, prospective evaluation of its impact, and survey of the information needs of the pharmacists].
    Claeys C; Dufrasne M; De Vriese C; Nève J; Tulkens PM; Spinewine A
    J Pharm Belg; 2015 Mar; (1):42-54. PubMed ID: 26571796
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Patient experiences and opinions on medication review: a qualitative study.
    Robberechts A; Van Loon L; Steurbaut S; De Meyer GRY; De Loof H
    Int J Clin Pharm; 2023 Jun; 45(3):650-658. PubMed ID: 36862254
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Implementation study of an intermediate medication review in Belgian community pharmacies.
    Lelubre M; Wuyts J; Maesschalck J; Duquet N; Foubert K; Hutsebaut C; Moullin J; De Wulf I; Boussery K; Foulon V; De Vriese C
    Res Social Adm Pharm; 2019 Jun; 15(6):710-723. PubMed ID: 30241873
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Medication reviews in community pharmacies: An approach to external quality assessment].
    Schröder J; Knoth H; Wolf S; Wegener M; Goltz L
    Z Evid Fortbild Qual Gesundhwes; 2023 Feb; 176():22-30. PubMed ID: 36697303
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The status of the performance of medication reviews in German community pharmacies and assessment of the practical performance.
    Greißing C; Kössler K; Freyer J; Hüter L; Buchal P; Schiek S; Bertsche T
    Int J Clin Pharm; 2016 Dec; 38(6):1425-1435. PubMed ID: 27783313
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Appropriateness of prescribing among elderly patients in a Dutch residential home: observational study of outcomes after a pharmacist-led medication review.
    Stuijt CC; Franssen EJ; Egberts AC; Hudson SA
    Drugs Aging; 2008; 25(11):947-54. PubMed ID: 18947262
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Individual medication management system (IMMS) implementation in pharmacists' opinion.
    Waszyk-Nowaczyk M; Lawicki S; Michalak M; Simon M
    Acta Pol Pharm; 2014; 71(3):509-14. PubMed ID: 25265831
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Design of the POINT study: Pharmacotherapy Optimisation through Integration of a Non-dispensing pharmacist in a primary care Team (POINT).
    Hazen AC; Sloeserwij VM; Zwart DL; de Bont AA; Bouvy ML; de Gier JJ; de Wit NJ; Leendertse AJ
    BMC Fam Pract; 2015 Jul; 16():76. PubMed ID: 26135582
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pharmaceutical counseling: Between evidence-based medicine and profits.
    Egorova SN; Akhmetova T
    Int J Risk Saf Med; 2015; 27 Suppl 1():S87-8. PubMed ID: 26639727
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Implementation of a mental health medication management intervention in Australian community pharmacies: Facilitators and challenges.
    Hattingh HL; Kelly F; Fowler J; Wheeler AJ
    Res Social Adm Pharm; 2017; 13(5):969-979. PubMed ID: 28583302
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Assessment of Pharmacists' Willingness to Conduct Medication Use Reviews in Poland.
    Merks P; Religioni U; Waszyk-Nowaczyk M; Kaźmierczak J; Białoszewski A; Blicharska E; Kowalczuk A; Neumann-Podczaska A
    Int J Environ Res Public Health; 2022 Feb; 19(3):. PubMed ID: 35162889
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Implementation of a medication therapy management collaborative within a pediatric health system.
    Sneed G; Kappeler K; Gilmore T; Kuhn C
    J Am Pharm Assoc (2003); 2018; 58(4S):S114-S119. PubMed ID: 29871801
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Public attitudes towards community pharmacy in Arabic speaking Middle Eastern countries: A systematic review.
    El Hajj MS; Mekkawi R; Elkaffash R; Saleh R; El Awaisi A; Wilbur K
    Res Social Adm Pharm; 2021 Aug; 17(8):1373-1395. PubMed ID: 33257161
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Forging a novel provider and payer partnership in Wisconsin to compensate pharmacists for quality-driven pharmacy and medication therapy management services.
    Trapskin K; Johnson C; Cory P; Sorum S; Decker C
    J Am Pharm Assoc (2003); 2009; 49(5):642-51. PubMed ID: 19748873
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Examining the association between the "My Pharmacist" model and the service quality of community pharmacies.
    Goto K; Sato T; Shikamura Y; Nomura K; Negishi K; Hanawa T
    Res Social Adm Pharm; 2020 Jul; 16(7):958-966. PubMed ID: 31839583
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Current Perceptions and Improvement Approaches of Pharmaceutical Care Capacity of Community Pharmacists: A Quantitative Analysis Based on Survey Data at Chinese Chain Pharmacies.
    Tang Z; Lhamu P; Ye H; Hong L; Xiang X
    Int J Environ Res Public Health; 2020 Oct; 17(20):. PubMed ID: 33066654
    [No Abstract]   [Full Text] [Related]  

  • 18. Implementation of a pharmacist-led transitional pharmaceutical care programme: Process evaluation of Medication Actions to Reduce hospital admissions through a collaboration between Community and Hospital pharmacists (MARCH).
    En-Nasery-de Heer S; Uitvlugt EB; Bet PM; van den Bemt BJF; Alai A; van den Bemt PMLA; Swart EL; Karapinar-Çarkit F; Hugtenburg JG
    J Clin Pharm Ther; 2022 Jul; 47(7):1049-1069. PubMed ID: 35306683
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Community pharmacy advanced adherence services for children and young people with long-term conditions: A cross-sectional survey study.
    Alsairafi Z; Mason J; Davies N; Dennis M; Pilgrim G; Goel N; Yahyouche A; Jalal Z
    Pharm Pract (Granada); 2020; 18(1):1720. PubMed ID: 32256895
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Probing pharmacists' interventions in Long-Term Care: a systematic review.
    Gonçalves JR; Ramalhinho I; Sleath BL; Lopes MJ; Cavaco AM
    Eur Geriatr Med; 2021 Aug; 12(4):673-693. PubMed ID: 33743169
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.